Adriana Mulero-Russe , Ana Mora-Boza , Elijah N. Marquez , Morgan Ziegelski , Michael Helmrath , Andrés J. García
{"title":"Synthetic hydrogel substrate for human induced pluripotent stem cell definitive endoderm differentiation","authors":"Adriana Mulero-Russe , Ana Mora-Boza , Elijah N. Marquez , Morgan Ziegelski , Michael Helmrath , Andrés J. García","doi":"10.1016/j.biomaterials.2024.122920","DOIUrl":null,"url":null,"abstract":"<div><div>Human induced pluripotent stem cells (hiPSCs) can give rise to multiple lineages derived from three germ layers, endoderm, mesoderm and ectoderm. Definitive endoderm (DE) cell types and tissues have great potential for regenerative medicine applications. Current hiPSC differentiation protocols focus on the addition of soluble factors; however, extracellular matrix properties are known to also play a role in dictating cell fate. Matrigel™ is the gold standard for DE differentiation, but this xenogeneic, poorly defined basement membrane extract limits the clinical translatability of DE-derived tissues. Here we present a fully defined PEG-based hydrogel substrate to support hiPSC-derived DE differentiation. We screened hydrogel formulations presenting different adhesive peptides and matrix stiffness. Our results demonstrate that presenting a short peptide, cyclic RGD, on the engineered PEG hydrogel supports the transition from undifferentiated hiPSCs to DE using a serum-free, commercially available kit. We show that increasing substrate stiffness (G’ = 1.0–4.0 kPa) results in an increased linear response in DE differentiation efficiency. We also include a temporal analysis of the expression of integrin and syndecan receptors as the hiPSCs undergo specification towards DE lineage. Finally, we show that focal adhesion kinase activity regulates hiPSC growth and DE differentiation efficiency. Overall, we present a fully defined matrix as a synthetic alternative for Matrigel™ supporting DE differentiation.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"315 ","pages":"Article 122920"},"PeriodicalIF":12.8000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomaterials","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S014296122400454X","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Human induced pluripotent stem cells (hiPSCs) can give rise to multiple lineages derived from three germ layers, endoderm, mesoderm and ectoderm. Definitive endoderm (DE) cell types and tissues have great potential for regenerative medicine applications. Current hiPSC differentiation protocols focus on the addition of soluble factors; however, extracellular matrix properties are known to also play a role in dictating cell fate. Matrigel™ is the gold standard for DE differentiation, but this xenogeneic, poorly defined basement membrane extract limits the clinical translatability of DE-derived tissues. Here we present a fully defined PEG-based hydrogel substrate to support hiPSC-derived DE differentiation. We screened hydrogel formulations presenting different adhesive peptides and matrix stiffness. Our results demonstrate that presenting a short peptide, cyclic RGD, on the engineered PEG hydrogel supports the transition from undifferentiated hiPSCs to DE using a serum-free, commercially available kit. We show that increasing substrate stiffness (G’ = 1.0–4.0 kPa) results in an increased linear response in DE differentiation efficiency. We also include a temporal analysis of the expression of integrin and syndecan receptors as the hiPSCs undergo specification towards DE lineage. Finally, we show that focal adhesion kinase activity regulates hiPSC growth and DE differentiation efficiency. Overall, we present a fully defined matrix as a synthetic alternative for Matrigel™ supporting DE differentiation.
人类诱导多能干细胞(hiPSCs)可产生源自三个胚层(内胚层、中胚层和外胚层)的多系细胞。明确的内胚层(DE)细胞类型和组织在再生医学应用方面具有巨大潜力。目前的 hiPSC 分化方案侧重于添加可溶性因子;但众所周知,细胞外基质的特性也在决定细胞命运方面发挥作用。Matrigel™ 是 DE 分化的黄金标准,但这种异种、定义不清的基底膜提取物限制了 DE 衍生组织的临床转化能力。在这里,我们提出了一种完全定义的基于 PEG 的水凝胶基底,以支持 hiPSC 衍生的 DE 分化。我们筛选了具有不同粘附肽和基质硬度的水凝胶配方。我们的结果表明,使用无血清的市售试剂盒,在工程化 PEG 水凝胶上呈现短肽(环状 RGD)可支持未分化的 hiPSC 向 DE 过渡。我们的研究表明,增加基质硬度(G' = 1.0-4.0 kPa)可提高 DE 分化效率的线性响应。我们还对 hiPSCs 向 DE 株系分化过程中整合素和辛迪加受体的表达进行了时间分析。最后,我们展示了局灶粘附激酶活性对 hiPSC 生长和 DE 分化效率的调节作用。总之,我们提出了一种完全确定的基质,作为支持 DE 分化的 Matrigel™ 的合成替代物。
期刊介绍:
Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.